Business Context and Reporting Period
Company: Humana Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2009
Business Overview: Humana is a full-service benefits solutions company offering health and supplemental benefit products to employer groups, government programs, and individuals. As of March 31, 2009, the company served approximately 10.4 million medical members and 6.7 million specialty product members. Operations are divided into two segments: Government (Medicare, Military, Medicaid) and Commercial.
Key Financial Metrics
| Metric (in thousands, except per share) | Q1 2009 | Q1 2008 |
|---|---|---|
| Total Revenues | $7,711,661 | $6,959,704 |
| Net Income | $205,717 | $80,170 |
| Diluted EPS | $1.22 | $0.47 |
| Operating Cash Flow | $45,520 | $4,439 |
| Cash and Cash Equivalents | $1,911,202 | $1,688,287 |
| Long-Term Debt | $1,934,856 | $1,937,032 |
| Benefit Ratio (Total) | 83.9% | 86.7% |
| SG&A Expense Ratio (Total) | 13.9% | 13.8% |
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased 10.8% year-over-year, driven by an 11.3% increase in premium revenues. Government segment premiums rose 13.7% due to Medicare Advantage growth, while Commercial premiums increased 4.2%.
- Profitability Surge: Net income more than doubled to $205.7 million from $80.2 million. This was primarily driven by a significant improvement in the Government segment, which turned a loss of $3.2 million in Q1 2008 into a profit of $166.1 million in Q1 2009.
- Benefit Ratio Improvement: The consolidated benefit ratio improved by 280 basis points to 83.9%, largely due to lower Medicare stand-alone Part D (PDP) claims expenses following a realignment of premium and benefit structures.
- Membership Shifts: Medicare Advantage membership grew 15.9% to 1.47 million. Conversely, Medicare stand-alone PDP membership declined 34.0% to 2.08 million. Commercial medical membership remained relatively flat (up 0.4%) despite economic headwinds.
- Investment Portfolio: Gross unrealized losses on investment securities totaled $369.8 million, primarily due to widening credit spreads. However, management determined these losses were temporary, and no impairment charges were recorded.
Guidance, Outlook, and Risks
- Outlook: Management expects net Medicare Advantage membership to grow by approximately 50,000 members in 2009. Operating cash flows for the full year 2009 are projected between $1.2 billion and $1.4 billion, with the majority expected in the second half of the year.
- Regulatory Impact: CMS announced a 4% to 5% effective rate decrease for Medicare Advantage plans in 2010. Humana must adjust bids by June 1, 2009, potentially requiring premium increases or benefit reductions.
- TRICARE Contract: The government exercised its option to extend the TRICARE South Region contract through March 31, 2010. A new nationwide TRICARE contract award is expected in Q2 2009 for 2010 implementation.
- Legal Proceedings: The company faces significant litigation, including consolidated securities class actions alleging misleading earnings guidance and internal control weaknesses, as well as provider class actions regarding TRICARE reimbursement rates. Outcomes are uncertain and could materially affect financial results.
- Market Risk: Continued volatility in financial markets poses risks to investment portfolio fair value and liquidity. Humana maintains a BBB credit rating; a downgrade could increase interest costs on senior notes.
Investor Verification Checklist
- Medicare Rate Adjustments: Verify the impact of the 4-5% CMS rate cut on 2010 profitability and the company's ability to maintain competitiveness.
- Legal Exposure: Monitor the status of the securities class action and TRICARE provider litigation for potential settlement costs or adverse rulings.
- Investment Impairments: Track the $369.8 million in gross unrealized losses to ensure they remain classified as temporary and do not require future write-downs.
- Commercial Membership: Assess the sustainability of commercial membership given the recessionary environment and workforce reductions affecting small-group accounts.
- Cash Flow Timing: Confirm the second-half concentration of operating cash flows aligns with the projected $1.2-$1.4 billion range.